...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Financial Statement Q2, 2023 /MD&A

I think Don's incompetence was hidden during the BoM trial and then masked again during the initial Covid trial and Eversana phases.

Since then it has beome quite apparent that "the emperor has no clothes".

But relax, and be confident, as Don resassured us they are looking for money in the middle east. So I imagine that Don and his diligent team are on a golf course (sweating it out) with some wealthy sheiks in Algeria, Egypt, Iran or another middle eastern country hoping for a pot of gold on the 19th green.

With a competent CEO this company would agressively have trials running not only on BoM2 but also PAH, Fabry, HIV, Covid and numerous opportunities in CKD, etc. A competent CEO would also have the confidence to give shareholders a clear and honest description and accounting of what really happened in the Covid trials and also information about the discussions they have been having(or not) with BPs and other suitors not in terms of confidentiaal information but in general terms about the types of interest and resistance coming from suitors.

We also deserve an honest discussion about the science of BET inhibitors and apabetalone and some input from RVX scientists about apabetalone's strenghts and weaknesses and expectations.

The current situation is so pathetic that the only response is to laugh about it if I didn't have so much hope for apabetalone, the benefits to society and my own money tied up in this.

Any competent BOD would have been fired the CEO yeras ago. The BOD is clearly incompetent.

Anyway, that is my POV and Sunday rant. Who knows what tomorrow will bring...a rabit out of a hat?        :)

GLTA

Toinv

Share
New Message
Please login to post a reply